Literature DB >> 8382509

Neutrophil chemotactic factors produced by malignant fibrous histiocytoma cell lines.

M Yoshida1, H Matsuzaki, H Hata, F Matsuno, M Takeya, H Okabe, K Takatsuki.   

Abstract

The clinicopathological features of malignant cells are sometimes modified by autologous cytokine production. Inflammatory fibrous histiocytoma (IFH) is characterised by leukocyte infiltration and is a variant of malignant fibrous histiocytoma (MFH). We demonstrated that three MFH cell lines (MF-1, MF-3, and MF-4) have the potential to promote neutrophil chemotaxis and to express mRNA for the cytokines, granulocyte-macrophage colony stimulating factor (GM-CSF) and/or interleukin 8/neutrophil attractant/activation protein 1 (IL-8/NAP-1), both with and without interleukin 1 beta (IL-1 beta) stimulation. MF-1 cells showed the spontaneous production of neutrophil chemotactic activity and the expression of both of GM-CSF and IL-8/NAP-1 mRNA, which was enhanced by exogenous IL-1 beta. In contrast, MF-3 cells showed the expression of GM-CSF and IL-8/NAP-1 mRNA with IL-1 beta stimulation but not without it, and MF-4 cells expressed only IL-8/NAP-1 mRNA when stimulated with IL-1 beta (time- and dose-dependent expression). These findings suggest that neutrophil chemotactic cytokines derived from IFH cells might be responsible for the prominent infiltration of neutrophils in this disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382509      PMCID: PMC1968275          DOI: 10.1038/bjc.1993.95

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system.

Authors:  E Van Meir; M Ceska; F Effenberger; A Walz; E Grouzmann; I Desbaillets; K Frei; A Fontana; N de Tribolet
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

2.  Neutrophil chemotactic factors produced by a cell line from thyroid carcinoma.

Authors:  M Yoshida; H Matsuzaki; K Sakata; M Takeya; K Kato; S Mizushima; M Kawakita; K Takatsuki
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

3.  Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells.

Authors:  C Zoja; J M Wang; S Bettoni; M Sironi; D Renzi; F Chiaffarino; H E Abboud; J Van Damme; A Mantovani; G Remuzzi
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

4.  Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Authors:  F M Brennan; C O Zachariae; D Chantry; C G Larsen; M Turner; R N Maini; K Matsushima; M Feldmann
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

5.  Expression of granulocyte and granulocyte-macrophage colony-stimulating factors by human non-hematopoietic tumor cells.

Authors:  K Tani; K Ozawa; H Ogura; M Shimane; N Shirafuji; T Tsuruta; J Yokota; S Nagata; Y Ueyama; F Takaku
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

6.  Inflammatory fibrous histiocytoma presenting leukemoid reaction.

Authors:  K Takahashi; Y Kimura; M Naito; T Yoshimura; H Uchida; S Araki
Journal:  Pathol Res Pract       Date:  1989-05       Impact factor: 3.250

7.  Production of monocyte chemoattractant protein-1 by malignant fibrous histiocytoma: relation to the origin of histiocyte-like cells.

Authors:  M Takeya; T Yoshimura; E J Leonard; T Kato; H Okabe; K Takahashi
Journal:  Exp Mol Pathol       Date:  1991-02       Impact factor: 3.362

8.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.

Authors:  M Seitz; B Dewald; N Gerber; M Baggiolini
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

9.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

Authors:  T Yoshimura; K Matsushima; J J Oppenheim; E J Leonard
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

10.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.

Authors:  K Matsushima; K Morishita; T Yoshimura; S Lavu; Y Kobayashi; W Lew; E Appella; H F Kung; E J Leonard; J J Oppenheim
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  3 in total

1.  Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.

Authors:  Hirofumi Nakanishi; Kiyoko Yoshioka; Susumu Joyama; Nobuhito Araki; Akira Myoui; Shingo Ishiguro; Takafumi Ueda; Hideki Yoshikawa; Kazuyuki Itoh
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

2.  Soft tissue paraspinal inflammatory malignant fibrous histiocytoma presenting as a lumbar abscess.

Authors:  Emmanouil Liarmakopoulos; Pavlos Lampropoulos; Athanasios Marinis; Charalambos Markakis; Kassiani Manoloudaki; Andreas Chatzimarkou; Spyros Rizos
Journal:  Case Rep Oncol       Date:  2011-07-09

3.  A case of primary gastric undifferentiated high-grade pleomorphic sarcoma diagnosed with chief complaint of fever: a case report and literature review.

Authors:  Akira Kabashima; Koichi Kimura; Kensaku Sanefuji; Satoru Masunari; Seiji Haraoka; Soichiro Maekawa
Journal:  Surg Case Rep       Date:  2017-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.